CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-10 | Suria Hamza President, CEO | Sale | −10,347 | $71.49 | $740K | 40,026 |
| 2018-12-10 | Suria Hamza President, CEO | Sale | −4,964 | $72.48 | $360K | 35,062 |
| 2018-12-10 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −30,587 | 110,361 | ||
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Exercise or conversion | +37,000 | $11.34 | $420K | 37,000 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Sale | −3,554 | $70.34 | $250K | 33,446 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Sale | −18,604 | $71.33 | $1.3M | 14,842 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Sale | −4,820 | $72.24 | $348K | 10,022 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Sale | −2,298 | $73.18 | $168K | 7,724 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Sale | −6,624 | $74.33 | $492K | 1,100 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Sale | −1,100 | $75.81 | $83K | 0 |
| 2018-12-03 | Piscitelli Dominic Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −37,000 | 133,241 | ||
| 2018-09-07 | Londei Marco Chief Medical Officer | Exercise or conversion | +142,857 | $0.70 | $100K | 144,877 |
| 2018-09-07 | Londei Marco Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −142,857 | 18,108 | ||
| 2018-08-06 | LOUMEAU ERIC J General Counsel | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-09 | Suria Hamza President, CEO | Exercise or conversion | +1,428 | $2.24 | $3K | 28,854 |
| 2018-07-09 | Suria Hamza President, CEO | Exercise or conversion | +6,208 | $1.61 | $10K | 35,062 |
| 2018-07-09 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −1,428 | 0 | ||
| 2018-07-09 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −6,208 | 0 | ||
| 2018-06-08 | Suria Hamza President, CEO | Exercise or conversion | +22,428 | $2.59 | $58K | 27,426 |
| 2018-06-08 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −22,428 | 0 |
Page 30 of 36 · 714 trades